Delivery Order SPE2DB25D3110-SPE2DB25FTEGD
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Sorafenib 200 mg tablets in quantities of 120 units, with a ceiling value of $28,126.60. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 8, 2025, with performance at the vendor's Conshohocken, Pennsylvania location. The contract carries no set-aside designation, reflecting AmerisourceBergen's capability to compete successfully...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Sorafenib 200 mg tablets (120-count) with a ceiling value of $45,892.39. This firm fixed-price delivery order, awarded on September 11, 2025, represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location in Conshohocken,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The contract, valued at $41,401.36, is for the supply of 120-count tablets of the cancer medication Sorafenib 200 mg. It is a firm fixed-price delivery order contract with an ultimate completion date of April 10, 2024. No set-aside designation was used for this award. In addition to this...
- The Defense Logistics Agency awarded a $8,736 delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Nexavar 200 mg tablets (120 count). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 26, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's broader Indefinite Delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $46,371.84, is for the delivery of 120 tablets of the medication Sorafenib 200 mg. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of April 3, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division provides for the delivery of 4,564,753,052 units of Sorafenib 200 mg tablets to the U.S. government. The contract, valued at $33,960.52, is a firm fixed-price delivery order with a period of performance through May 31, 2024. It was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a major procurement arm of the Department of Defense (DoD). Amerisourcebergen, a leading pharmaceutical...
- This federal contract award, valued at $16,253.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4564742986 - Sorafenib 200 mg Tablets in 120-count bottles, with a completion date of May 30, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,272.22 firm fixed-price delivery order is for the provision of 120 tablets of the drug Sorafenib 200 mg. The contract has an ultimate completion date of February 4, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November...
- The federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Sorafenib 200 mg tablets. The contract, valued at $18,759.23, is a Firm Fixed Price Delivery Order with an ultimate completion date of August 1, 2024. This award is not associated with any set-aside program. As a significant supplier of pharmaceutical products and medical supplies to the U.S. federal government, Amerisourcebergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Sunitinib Malate 37.5 mg capsules (28-count units) with a ceiling value of $11,228.08. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an existing indefinite delivery contract vehicle. The contract specifies a place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025, and...
- SPE2DB25D3110Indefinite Delivery Contract
- SPE2DB25D3110-SPE2DB25FTEGDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Sorafenib 200 mg tablets (120-count) with a ceiling value of $7,385.11. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 4, 2025, and will be performed at the vendor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed among qualified vendors in the open market. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a prime vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies a broad portfolio of pharmaceutical products and medical commodities to support military healthcare systems and other federal agencies including the Defense Health Agency and U.S. Coast Guard. The Sorafenib supply under this delivery order represents part of the company's ongoing role in providing critical medications through DLA's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.4k | 9/3/25 |